Table 1 Treatment efficacy at 6 months in patients under HAIC
From: Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Parameter | GI IACT (n = 21) |
|---|---|
Efficacy at 6 months [n (%)] | |
Complete response (CR) | 0 (0.0%) |
Partial response (PR) | 0 (0.0%) |
Stable disease (SD) | 1 (4.8%) |
Progressive disease (PD) | 20 (95.2%) |
Response rate | 0 (0.0%) |
Disease control rate | 1 (5.6%) |
Progression-free survival (months) | |
Mean ± SD | 2.24 ± 0.88 |
Median | 2.00 |
Range (min–max) | 2.00—6.00 |
Overall survival (months) | |
Mean ± SD | 5.72 ± 0.89 |
Median | 6.00 |
Range (min–max) | 2.00—6.00 |